Q32 Bio Inc. 8-K Filing
Ticker: QTTB · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Q32 Bio Inc. (ticker: QTTB) to the SEC on Jan 13, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ich registered Common stock, par value $0.0001 per share QTTB The Nasdaq Global Ma).
How long is this filing?
Q32 Bio Inc.'s 8-K filing is 2 pages with approximately 508 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-01-13 07:30:30
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share QTTB The Nasdaq Global Ma
Filing Documents
- d753173d8k.htm (8-K) — 24KB
- d753173dex991.htm (EX-99.1) — 44KB
- g753173ex99_1p10g1.jpg (GRAPHIC) — 431KB
- g753173ex99_1p11g1.jpg (GRAPHIC) — 428KB
- g753173ex99_1p12g1.jpg (GRAPHIC) — 465KB
- g753173ex99_1p13g1.jpg (GRAPHIC) — 421KB
- g753173ex99_1p14g1.jpg (GRAPHIC) — 412KB
- g753173ex99_1p15g1.jpg (GRAPHIC) — 230KB
- g753173ex99_1p16g1.jpg (GRAPHIC) — 335KB
- g753173ex99_1p17g1.jpg (GRAPHIC) — 322KB
- g753173ex99_1p18g1.jpg (GRAPHIC) — 169KB
- g753173ex99_1p19g1.jpg (GRAPHIC) — 351KB
- g753173ex99_1p1g1.jpg (GRAPHIC) — 408KB
- g753173ex99_1p20g1.jpg (GRAPHIC) — 354KB
- g753173ex99_1p21g1.jpg (GRAPHIC) — 359KB
- g753173ex99_1p22g1.jpg (GRAPHIC) — 286KB
- g753173ex99_1p23g1.jpg (GRAPHIC) — 428KB
- g753173ex99_1p24g1.jpg (GRAPHIC) — 168KB
- g753173ex99_1p25g1.jpg (GRAPHIC) — 241KB
- g753173ex99_1p26g1.jpg (GRAPHIC) — 304KB
- g753173ex99_1p27g1.jpg (GRAPHIC) — 352KB
- g753173ex99_1p28g1.jpg (GRAPHIC) — 309KB
- g753173ex99_1p29g1.jpg (GRAPHIC) — 273KB
- g753173ex99_1p2g1.jpg (GRAPHIC) — 847KB
- g753173ex99_1p30g1.jpg (GRAPHIC) — 283KB
- g753173ex99_1p31g1.jpg (GRAPHIC) — 340KB
- g753173ex99_1p32g1.jpg (GRAPHIC) — 256KB
- g753173ex99_1p33g1.jpg (GRAPHIC) — 351KB
- g753173ex99_1p34g1.jpg (GRAPHIC) — 377KB
- g753173ex99_1p3g1.jpg (GRAPHIC) — 460KB
- g753173ex99_1p4g1.jpg (GRAPHIC) — 196KB
- g753173ex99_1p5g1.jpg (GRAPHIC) — 169KB
- g753173ex99_1p6g1.jpg (GRAPHIC) — 442KB
- g753173ex99_1p7g1.jpg (GRAPHIC) — 478KB
- g753173ex99_1p8g1.jpg (GRAPHIC) — 462KB
- g753173ex99_1p9g1.jpg (GRAPHIC) — 460KB
- 0001193125-25-004976.txt ( ) — 16963KB
- qttb-20250113.xsd (EX-101.SCH) — 3KB
- qttb-20250113_lab.xml (EX-101.LAB) — 17KB
- qttb-20250113_pre.xml (EX-101.PRE) — 11KB
- d753173d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. 99.1 Corporate presentation, dated as of January 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Q32 BIO INC. Date: January 13, 2025 By: /s/ Jodie Morrison Name: Title: Jodie Morrison Chief Executive Officer